July 02, 2012
Phillips & Cohen whistleblower case settles as part of record Glaxosmithkline settlement
WASHINGTON, DC – Two whistleblowers represented by Phillips & Cohen provided the critical evidence that launched massive government investigations into Glaxosmithkline’s marketing practices,...
Posted In Phillips & Cohen News
Glaxo settles record whistleblower case for $3 billion – Medicare fraud alleged
WASHINGTON, DC – Two whistleblowers represented by Phillips & Cohen LLP provided the government with overwhelming evidence that was at the heart of the government’s case against GlaxoSmithKline...
Posted In Phillips & Cohen News
April 27, 2012
“Can The SEC Be Trusted To Protect A Whistleblower’s Identity?”
Article by Erika A. Kelton published in Forbes, 4/27/12. The whistleblower world and Wall Street are abuzz with the question of whether the Securities and Exchange Commission inadvertently revealed the...
April 25, 2012
Phillips & Cohen whistleblower attorney testifies about Medicaid fraud enforcement
WASHINGTON, DC – Whistleblowers are an important part of the enforcement effort to uncover and stop Medicaid fraud, Claire M. Sylvia, a whistleblower attorney with Phillips & Cohen LLP, said...
Posted In Phillips & Cohen News
April 23, 2012
Phillips & Cohen represents Common Cause in IRS whistleblower case against ALEC
WASHINGTON, DC – Phillips & Cohen LLP is representing Common Cause in a whistleblower case filed with the Internal Revenue Service (IRS) last week that says the American Legislative Exchange...
Posted In Phillips & Cohen News
ATK settles Phillips & Cohen whistleblower case for $37 million
SALT LAKE CITY, UT – The whistleblower whose False Claims Act case against a wholly owned subsidiary of Alliant Techsystems (NYSE: ATK) settled for about $37 million said he was pleased with the...
Posted In Phillips & Cohen News
March 28, 2012
P&C Texas whistleblower lawsuit against Hawthorn Pharmaceuticals in Mississippi settles for $2.8 million
PLANO, TX – Hawthorn Pharmaceuticals Inc. and its parent company, Cypress Pharmaceutical Inc., have paid the federal government and certain states a total of $2.8 million to settle a whistleblower...
Posted In Phillips & Cohen News
January 31, 2012
Whistleblower attorney John Phillips part of national False Claims Act 25th anniversary commemoration
WASHINGTON, DC – A whistleblower law passed 25 years ago to little fanfare has helped the government recover more than $30 billion and become the government’s most successful weapon in the...
Posted In Phillips & Cohen News
January 24, 2012
Phillips & Cohen whistleblower lawyers warn House bill would kill SEC program
WASHINGTON, DC – A House bill that would make major changes to the Securities & Exchange Commission’s new whistleblower program would essentially kill an important enforcement tool for...
Posted In Phillips & Cohen News
January 10, 2012
Whistleblower attorney Erika Kelton responds to claims about Jazz Pharmaceuticals off-label case
NEW YORK CITY, NY – The Wall Street Journal published on Jan. 4, 2012, an edited version of the following letter to the editor written by Phillips & Cohen partner Erika A. Kelton, who represented...
Posted In Phillips & Cohen News